ClinicalTrials.Veeva

Menu

The Treatment Effect of Chinese Herbal Compound Ointment on Atrophic Vaginitis

Sun Yat-sen University logo

Sun Yat-sen University

Status and phase

Unknown
Phase 1

Conditions

Atrophic Vaginitis

Treatments

Drug: Chinese Herbal Compound Ointment
Drug: Estriol

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Objective:To evaluate the effect and safety of the traditional chinese medicine oil agent on senile atrophic compared as compared to estriol cream in aged woman.

Design: A randomized double-blind controlled trial.

Setting: The hospital ward.

Participants: 200 postmenopausal woman with senile vaginitis (mean age 56).

Intervention: The traditional chinese medicine oil and estriol cream were separately intravaginal administrated in treatment group and control group for 3 weeks,follow-up 1 month.

Measurement: symptom improving(pain and itch) and onset time, edema-size of vaginal wall, vaginal discharge, and PH changes.

Full description

80 postmenopausal women living in the communities near the hospital with AV (atrophic vaginitis) symptoms were recruited for this clinical trial. Patients with AV receiving external treatment and requiring hospitalization were randomized in a double-blind, single-centre trial. Subjects received CHCO (Chinese Herbal Compound Ointment) topical vaginal application in experimental group, while estriol in control group. The dosage of medicine for single treatment once a day in two group is 0.5g.The total time for therapy is 3 weeks in two groups. Assessment indicators:vagine PH, sIgA and IL-1βchanges, the degree of symptoms improving, onset time, edema-size of vaginal wall, vaginal discharge, and relapses and retreatment effect.

Enrollment

80 estimated patients

Sex

Female

Ages

50 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Postmenopausal women
  • With typical clinical manifestations: virginal genital itching or burning sense, Increased vaginal secretions, a yellow, a serious bloody pus-like leucorrhea, or sexual intercourse pain
  • Gynecological examination: Vaginal epithelium atrophy,Vaginal folds flat or disappear, mucosal hyperemia, superficial ulceration
  • Both ALT and AST are normal or less than 2 times, bilirubin is normal
  • Serum creatinine level is within the normal range
  • ECG is normal;

Exclusion criteria

  • Gynecological and breast Oncology, endometrial hyperplasia(≥5mm)
  • Estrogenic drugs or probiotics used in four week
  • Participate in other clinical trials;Thrombotic diseases
  • Abnormal vaginal bleeding without clear diagnose
  • Estriol allergy
  • Severe pneumonia, tuberculosis, lung abscess, myocarditis
  • heart,liver or kidney failure(NYHA class III-IV,ALT to AST ratio twice more than upper limit of normal
  • sexually transmitted diseases;mental disorders

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

80 participants in 2 patient groups

Chinese Herbal Compound Ointment
Experimental group
Description:
This kind of CHCO composed of several chinese herbs,dong quai,angelica,resina draconis and lithospermum.The dosage of medicine for single treatment once a day in two group is 0.5g,The total time for therapy is 3 weeks.
Treatment:
Drug: Chinese Herbal Compound Ointment
Estriol
Active Comparator group
Description:
The dosage of medicine for single treatment once a day in two group is 0.5g,The total time for therapy is 3 weeks in two groups.
Treatment:
Drug: Estriol

Trial contacts and locations

1

Loading...

Central trial contact

Xin Zhou, master; Bao-guo Sun, Doctor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems